chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tired so quickly; Headache; back pain or the area of the lungs; like my asthma is worse; back pain or the area of the lungs; more like sore on the throat; Short of breath; coughing a few times; Throat pain; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249, expiration date unknown) via unspecified route of administration on left arm, on 16Jan2021, at a single dose for COVID-19 immunisation. The patient medical history included asthma. The concomitant medication were not reported. It was reported that on 19Jan2021, she had back pain, or the area of the lungs, headaches, throat pain, like more like sore on the throat, and she wasn't having too much coughing. She reported that initially she felt fine but 3 days later (19Jan2021), she began having shortness of breath "like my asthma is worse". She was coughing a few times, sporadically, not like one day coughing like crazy on 19Jan2021. On 26Jan2021, the patient tired so quickly even in her own place doing normal stuff, like cleaning and cooking. The patient used inhaler for short of breath which she usually did not use, like for year, and she saw it had already expired, and she got nervous that she saw it was expired, so she called her doctor to see if she could go, he said he was not receiving patients, all this stuff became so horrible. She tried to go to Urgent Care and they didn't see her, they said she had to go to the hospital, and she wanted to check her blood to see if she needs to receive the second shot or not, no one gave an answer, she doesn't know what to do, her second shot of vaccination was planned on 06Feb2021. Inhaler that was expired was Albuterol: expiry was Dec2020, lot DAEO68. During a call patient stated that the only symptom that worsened was short of breath. The patient wanted to know whether she could receive her second dose of vaccine. It was also reported that patient was not accepted in urgent care locations because she "may have covid" and was instructed to go to the ER (as reported). The patient assessed the events as non-serious. The patient was recovering from the events back pain or the area of the lungs, more like sore on the throat, coughing a few times, throat pain and headache and not recovered from other events.
On 09/30/2021 I had vaccination. About 05/01/2022 I noticed palpable lymphadenotomy. I went to my OBGYN on 04/12/2022 and they ordered an ultra sound where they confirmed deep bilateral nodes and lymphadenotomy: which were abnormal. I had a normal mammogram and SNA on 04/25/2022.
pt recvd vax;shrill cry 5-6 hrs p/ shots;crying started immed p/ receiving shots
Henoch Schonlein purpura: On Tuesday morning, Patient woke up feeling "a little crummy" but was able to go to school and felt fine the rest of the day. Denies rhinorrhea, congestion, cough, vomiting, or diarrhea. No sick contacts at home. No recent travel or illnesses. On Tuesday evening, she received her third Moderna COVID vaccine. The prior two vaccines were over a year ago and she had no reactions. She also recently received her flu vaccine 2 weeks prior without a reaction.    On Wednesday morning (day after vaccine), she woke up feeling sore /myalgias the whole day. She also had a dull intermittent headache at vertex scalp. She stayed in bed due to generalized malaise, but was able to eat and drink. Wednesday evening, she noticed a red dot on her dorsal foot. Shortly after, more red dots appeared on both dorsal feet and both ankles became edematous --palpable purpura. No rash elsewhere on the body. She then had difficulty walking due to pain. She presented to her PCP where they measured a fever of 104 and recommended that she go to the ED.
5:00am chills, cramping, nausea, mild vomiting (no food, empty stomach) 7:00am  chills, cramping, nausea, mild vomiting, fever 99.9 taken at 7:30am) Called doctor. Took Omeprazole and two tylenol at 8:00am.
sweats; Chills; feeling horrible; it was progression of the disease; tired; energy level was gone/wasn't strong; low fever; tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable consumer (patients mother).   A 98-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in right Arm on 17Jan2021 (Batch/Lot Number: EL9261) as SINGLE DOSE for covid-19 immunisation. Medical history included cholesterol, blood pressure, synthetic thyroid replacement, kidney and breast cancer survivor. Concomitant medication(s) included levothyroxine sodium (LEVOXYL) taken for thyroid therapy, start and stop date were not reported, vitamins,  Cholesterol medication, Blood Pressure medication. The patient previously had a flu shot.  The reporter said her 99-year-old mother received the 1st dose of the Pfizer-; had mild symptoms. Her mom is 99 and in good health. Her dad lived until 110. Her mom had first Pfizer shot through the assisted living facility on 17Jan2021. During routine testing her mom tested positive for COVID 25Jan2021. She had mild symptoms that started on the 26Jan2021. She was tired. Her energy level was gone and she had low fever. For prevention and to stay safe she had monoclonal antibodies infused on 29Jan2021. After that, she got really bad with fever and sweats. She never had trouble breathing. When taking her back from receiving the monoclonal antibodies, her mom had chills and was feeling horrible. They said it was progression of the disease. It took a month for her to get her strength back, but now she is great. She wasn't strong when she was due for second shot on 07Feb2021 and she didn't get it because they didn't want to stress her. She didn't have any stamina at that point. Now caller has been reading that some people say wait 90 days after monoclonal antibodies for the second dose. Her mom's thyroid doctor said not to give it. Her mom got better within the month, but would tire easily. She would be spent and couldn't do anymore. Now she is back to normal. She is up all day and stays up until 11PM.The outcome of the events was not reported.
Information has been received from a registered nurse concerning a patient who on an unspecified date was vaccinated with a dose of PNEUMOVAX 23 (lot#665708/0651Z). On the next day, the patient developed edema and cellulitis. At the time of this report, the patient's outcomes was not reported. Follow up information has been received which reported that the patient developed cellulitis following vaccination with PNEUMOVAX 23. Edema and cellulitis were considered to be disabling by the reporter. This is one of several reports from the same source. Additional information has been requested.
I laid down around 9:30 on the night of 11/03 with shortness of breath and very mild chest pain. It got progressively worse over the course of the next 3 hours, to the point that I decided to go to the ER. Hospital performed a chest x-ray, EKG, blood tests (CBC & D-dimer were 2 I'm aware of), and CT scan. Apparently my D-dimer was elevated, so they performed CT scan, which ruled out a pulmonary embolism. The doctor informed me it might have been a reaction to the vaccine, but was unable to determine the cause. I was discharged from the Hospital around 7:00AM on 11/04.  The chest pain subsided, but the shortness of breath has persisted since.   I'm still experiencing shortness of breath, but not to the same degree. Also, I will occasionally feel a mild tingling sensation in my hands and feet.
deceased Narrative: Patient was a 68M with advanced ALS, long-term need for mechanical ventilation, total care, TF, who developed worsening respiratory failure increasing difficulty with mech ventilation, unresponsive to COPD exacerbation treatment, in the setting of persistently abnormal CXR findings concerning for malignancy or other processes. After discussion with family, they did not want to patient to suffer any more and asked for mechanical ventilation be stopped after adequate comfort medications were administered. Patient was allowed to pass away naturally from his underlying advanced ALS.
drop in blood sugar level; This spontaneous case was reported by a consumer and describes the occurrence of HYPOGLYCAEMIA (drop in blood sugar level) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPOGLYCAEMIA (drop in blood sugar level). At the time of the report, HYPOGLYCAEMIA (drop in blood sugar level) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication information was provided. No treatment medication were provided.  The patient did not report any adverse reactions after the second dose.   Most recent FOLLOW-UP information incorporated above includes: On 10-Jul-2021: Added dose 2 details.
CHILLS; FEVER; MALAISE; HEADACHE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, treatment medications included: paracetamol. On 06-MAR-2021, the subject experienced chills. On 06-MAR-2021, the subject experienced fever. On 06-MAR-2021, the subject experienced malaise. On 06-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, fever, malaise, and headache. This report was non-serious.
Patient received flu shot on 10/12/12; she reported to employee health office on 10/15/12 with c/o redness/swelling at site (size of dollar (paper)) and painfulness. PO BENADRYL was given. She stated that it felt better now. Was worse the day before.
Patient had a pounding headache within 10 minutes of getting the vaccine. She said it resembled migraine but not a similar pattern as she had had in the past. Patient also felt nauseated.
This spontaneous report as received from (controlled) female consumer of 69year old. The patient's medical history included kidney problems and bipolar disorder. The patient's drug allergies/reactions and concomitant therapies were not provided. On the fall 2016, the patient was vaccinated with ZOSTAVAX, subcutaneously for vaccination (strength, dose, frequency, lot # and expiration date were not reported) while she was recovering from the flu. On an unknown date 2016 (also reported as 3 weeks after onset of therapy), the patient experienced pain in her legs and spine.  On an unspecified date, an unknown physician diagnosed her with unspecified nerve damage, so he prescribed physicial therapy, "a gel for pain" and tramadol (doses and frequencies not specified). On an unknown date, X-rays were performed (results not provided). The patient sought medical attention with her physician. The patient stated that she may need surgery on her spine to treat her condition and considered this as significant disability or incapacity. There was no intervention to prevent serious criteria. At the time of reporting, the outcome of spinal pain, nerve damage and pain in extremity was reported as not recovered. Additionally, the causality assessment between pain in extermity, spinal pain and nerve damage with ZOSTAVAX was not provided.
14-days post vaccine dose #1, swollen, itchy rash appeared around vaccine site. Medical attention sought through tele-health visit. Prescription for CEPHALEXIN 500 MG CAPSULE was written to rule out potential cellulitis. Consulting doctor felt it may be just a vaccine rash.
had fever 102.9 the afternoon  he had the immunizations ER diagnosed due to immunizations still febrile 09/29/2005 but only 101 and was acting fine.
multiple slightly softer bowel movements; next morning felt supercharged; This spontaneous case was reported by a consumer and describes the occurrence of FREQUENT BOWEL MOVEMENTS (multiple slightly softer bowel movements) and EUPHORIC MOOD (next morning felt supercharged) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FREQUENT BOWEL MOVEMENTS (multiple slightly softer bowel movements) and EUPHORIC MOOD (next morning felt supercharged). At the time of the report, FREQUENT BOWEL MOVEMENTS (multiple slightly softer bowel movements) and EUPHORIC MOOD (next morning felt supercharged) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report was received from a health care worker (medical assistant) regarding unknown number of patients of unknown gender and age. The reporter states that on an unknown date the patient's were vaccinated with VAQTA (dose, frequency, lot number, expiry date not reported). Also reported that the patient's were administered doses of VAQTA that were improperly stored and no adverse events were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
1405: Approximately 5 minutes post vaccination patient experienced light headedness, nausea," I could feel my heartbeat everywhere".  Patient A & O x4, skin pink, warm and dry, Allergies: Morphine, Amoxicillin PMHx: patient denies Meds: Patient denies Patient placed on gurney and assessed by EMS and Physician on duty and continued observation in first aid area.   Patient given water, and reported that symptoms were improving  1441: patient able to sit upright without symptoms. Cleared for to discharge home by Physician on duty.
Pain and hard to raise past shoulder.  Patient has taken tylenol and tried to stretch it and it is still in pain.
FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 74 year old male. The patient's height, and weight were not reported. The patient's past medical history included: ascorbic acid over dose, myocarditis, and pericarditis, and concurrent conditions included: hay fever, sulfa allergy, non smoker, alcohol user (occasionally red wine), and drug abuse/illicit drug usage. The patient was previously treated with cortisone. The patient had experienced guillain-barre syndrome when treated with influenza vaccine for prophylactic vaccination The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805025 expiry: 20-JAN-2022) dose was not reported, 1 total administered on 26-MAR-2021 to the right arm for covid-19 prophylaxis.  On an unspecified date the patient experienced a bump 2-3 inches below the top shoulder joint at the injection site, a little feverish, discomfort in arm, headache, not feeling well and soreness at the injection site (dose number in series 1). The soreness at the injection site, a little feverish and headache was for a week only. The patient received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 211D21A, expiry: 08-SEP-2022) dose was not reported, 1 total administered on 11-DEC-2021 to the right arm for covid-19 prophylaxis. Age at time of vaccination 74 years old. No concomitant medications were reported. On MAY-2022, the patient experienced flu like symptoms (dose number in series 2). On 27-JUL-2022, Laboratory data included: SARS-CoV-2 antibody test spike antibodies was high around 250 and mentioned SARS /cov/ 2 spike protein total AB semi-quantitative exceeding 250U/mL (less then 0.80 u/ml negative for Anti SARS antibody). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms. This report was non-serious. This case, from the same reporter is linked to 20211240426 (dose number in series 1).
99 yo obese DMII smoker reported during post-vaccination monitoring for Pfizer COVID 19 that she  was experiencing a  burning sensation without pain in her neck, hips and  along the spine area of her lower back. She reported feeling warm but stated it was likely a hot flash. She reported that when she has a flu shot she has localized arm burning sensation similar to this burning. Denies difficulty breathing, or swelling of any portion of her body. Patients states she is comfortable self-monitoring and plans to go to work.  Patient released to self  after monitoring for 1 hour. If patient later seeks medical care, we requested she inform us of the outcome.
sore arm for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for a couple of days) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939402 and 040C21A) for COVID-19 vaccination.     It was reported that the patient had never been diagnosed with/tested positive for COVID-19.  Patient was not given any other vaccines given within 1 month prior to Moderna COVID-19 vaccine.  The patient's past medical history included Nervous (hold a glass of water). Concurrent medical conditions included Penicillin allergy (Penicillin), Contrast media allergy (Allergy to X-ray dyes), Mitral valve prolapse (start date : all life), Hypertension (35 years ago), Cholesterol and Anxiety (hold a glass of water). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for Allergy, DIAZEPAM (VALIUM) for Anxiety, SIMVASTATIN for Cholesterol, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Hypersensitivity, DILTIAZEM for Mitral valve prolapse, VALPROATE SEMISODIUM (DEPAKOTE) for an unknown indication.   On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Aug-2021, the patient experienced PAIN IN EXTREMITY (sore arm for a couple of days). On 29-Aug-2021, PAIN IN EXTREMITY (sore arm for a couple of days) had resolved.            No treatment information was provided.   This case was linked to MOD-2022-536137, MOD-2022-536174 (Patient Link).
Pfizer-BioNTech COVID-19 Vaccine Vaccine recipient was a minor (15 years old and 8 months) at the time of vaccination with 1st dose. Care clinic notified by the department of health.
Pfizer COVID vaccine received on 02/28/2021, the second Pfizer COVID vaccine was received after the adverse reaction(9/17/2021)  on 10/2/2021 Hospitalized on 9/17/2021 at Hospital
The patient said she was "in perfect health" before the vaccine. After the vaccine was administered she suffered from a plugged ear and feels she is no hearing well.
Allergies, arthritis, balance problems, blood pressure varies, infection fungal, sleep insomnia, sleep problems, memory short terms memory loss, pain leg, pain lower back, arthritic pain in feet like electric shock, pain neck, walking difficulty, urinary frequency.03/27/07-records received from provider  DX:hyperlipidemia health maintenance impaired fasting glucose dental disorder obesity osteoarthrosis involving the knee disorders of bursae and tendons in shoulder region elevated liver function test HX:chronic cervical and lower back pain, recently had a right knee arthroscopy for meniscus tear 11/26/06. feels that epidural block administered during surgery has worsened his low back pain and persists with cervical pain. Sustained knee injury in Iraq.
I got the shot on February 7, 2022 at around 6 PM. On February 15, 2022 around 12 AM I woke up with awful chest pains, I tried multiple things to try and ease it off. I drank hot tea, soda to see if it was maybe a gas pain, took some tums, and when I got to clinical I talked to my instructor. She gave me a gas x and took me to get my Vital Signs. My blood pressure was 150/95 and my blood pressure is never that high, i'm a really healthy individual my blood pressure stays around 118/74. Later that night i started to have heart palpitations where it felt like my heart was beating out of my chest, excruciating chest pains, and shortness of breath. I went to the ER the next day and they were giving me medication to help with chest pain. They did an EKG, chest X-ray, and CT scan of my chest. I started to see a cardiologist about my chest pain and he has been running test and prescribed me medication. I told him i started to experience chest pains, heart palpitations, and shortness of breathe after the 1st dose of covid vaccine.
-Fever and chills; sore swollen arm -suggested taking ibuprofen and/or Tylenol -if symptoms don't resolve or get better by tomorrow, patient is going to call back
Got my shingles shot and reaction following the shots: swelling, redness, itchiness, soreness, tingling, numbness, shot area elevated.
Woke up with lump at injection site. Very painful, red, and hot to the touch.
This case was reported by a other health professional via call center representative and described the occurrence of elevated liver enzymes in a 78-year-old female patient who received SHINGRIX for prophylaxis. In January 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced elevated liver enzymes. On an unknown date, the outcome of the elevated liver enzymes was not recovered/not resolved. It was unknown if the reporter considered the elevated liver enzymes to be related to SHINGRIX. Additional details were reported as follows: The patient received the vaccine in the 1st or 2nd week of January 2018. She had routine blood work done prior to the vaccine and levels were normal. The patient had more blood work done after getting the vaccine and her liver enzymes were elevated. The reporter consented to follow-up. Lab Comments: Lab test performed on an unknown date, prior and after vaccination.
Information has been received from a physician concerning a 7 year old male, with no medical history and no allergies, who on 4/28/1999 was vaccinated with a first dose in the LAT  of varicella virus vaccine live (lot 629613/0285J). There were no concomitant medications. There was no illness at the time of vaccination and no adverse events following prior vaccination. On 5/16/2005 (also reported as 5/14/2005) the patient developed varicella with about 50 lesions. It was noted that no treatment was needed. The patients status was reported as recovering. There were no laboratory or diagnostic test performed. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information from a physician indicated that the patient developed a clinical case of chickenpox 6 years later, on 5/14/2005. Follow up information from a health professional indicated that the patient has fully recovered. Additional information is not expected.
At no specific time my vision became gradually worse. On Saturday afternoon "lightening" appeared in my right eye. I was unable to read at this point. It lasted about 15 minutes and the blurriness  (both eyes) remained all day.  This could also be a result of diabetes. I have an appointment with an ophthamologist in 3 days.